Triple-Class Exposed Relapsed and Refractory Multiple Myeloma
Triple-Class Exposed Relapsed and Refractory Multiple Myeloma
Jan 4, 2021
ajmc.com
Economic Impact of Migraines
Economic Impact of Migraines
Mar 31, 2020
ajmc.com
Prevalence, Costs, and Treatment of Alzheimer's Disease and Related Dementia: A Managed Care Perspective
Prevalence, Costs, and Treatment of Alzheimer's Disease and Related …
Aug 1, 2001
ajmc.com
Effect of Fexofenadine HC1 on Quality of Life and Work, Classroom, and Daily Activity Impairment in Patients with Seasonal Allergic Rhinitis
Effect of Fexofenadine HC1 on Quality of Life and Work, Classroo…
Apr 1, 1999
ajmc.com
Dr David M. O'Malley on Identifying Which Patients Will Respond to PARP Inhibitors
Dr David M. O'Malley on Identifying Which Patients Will Respond to P…
Mar 24, 2019
ajmc.com
Dr Swaminathan P. Iyer on Efficacy, Safety of CD70-Targeted CAR T-Cell Therapy in R/R T-Cell Lymphoma
Dr Swaminathan P. Iyer on Efficacy, Safety of CD70-Targeted CAR T-C…
Jun 11, 2022
ajmc.com
AURORA 2 Study of Voclosporin in LN Treatment
AURORA 2 Study of Voclosporin in LN Treatment
Dec 15, 2022
ajmc.com
Dr Mrinal Gounder: Nirogacestat Approval Provides First-in-Class …
Dec 8, 2023
ajmc.com
Dr Nicolas Girard on LUMINOSITY: Teliso-V Improves PROs in NSCLC
11 months ago
ajmc.com
Dr Joshua Rein Offers Insights on Cannabis Use for Chronic Kidney …
Oct 25, 2020
ajmc.com
Part 3: Dr James Robinson on the Impact of 340B Programs and Dru…
Feb 23, 2024
ajmc.com
An Overview of B-Cell Malignancies
Jan 21, 2020
ajmc.com
Dr Imran Khan Addresses Teclistamab’s Groundbreaking Im…
Mar 12, 2024
ajmc.com
How SURPASS-CVOT Spotlights Tirzepatide for Cardiovascular Out…
Jul 28, 2023
ajmc.com
ANNEXA-I Study Overview
Nov 27, 2023
ajmc.com
Dr John Burke: POLARIX Shows Marked Improvement in Patient O…
Dec 14, 2021
ajmc.com
Dr Jonathan Silverberg: Trial Washout Periods Are Methodologi…
Apr 23, 2021
ajmc.com
Explaining Molecular Residual Disease
Dec 22, 2021
ajmc.com
Using Lenalidomide and Pomalidomide in RRMM Managem…
Jun 21, 2022
ajmc.com
FDA Approves Fifth Neulasta Biosimilar
Jun 2, 2022
ajmc.com
Dr Patrick Burnett Explains Mechanism of Action for Roflumil…
Aug 25, 2022
ajmc.com
ASH 2020 Data: DKd Versus DVd Implications
Jan 27, 2021
ajmc.com
Dr David Rosmarin on Tailored Biologic Treatments, New Vitiligo …
Mar 27, 2022
ajmc.com
Dr Gabriel Hortobagyi on NATALEE Trial Outcomes and Future Resear…
Dec 8, 2023
ajmc.com
Operational Challenges and Collaborative Solutions in Cell an…
6 days ago
ajmc.com
2024 ASPC Congress on CVD Prevention to Be Held in August
Jul 8, 2024
ajmc.com
New CAR T Trial in MM Aims for Triple Receptor Targeting
Aug 24, 2024
ajmc.com
Dabrafenib Plus Trametinib Approved as First Tumor-Agnosti…
Jun 22, 2022
ajmc.com
Key Areas of Research and Emerging Therapies In Bronchiect…
Feb 2, 2024
ajmc.com
Dr Laurie Slovarp Outlines the Benefits of Behavioral Cough Sup…
Jun 12, 2021
ajmc.com
See more videos
Static thumbnail place holder